Since 2012, CALCiViS has raised close over £14 million in equity and grant funding. Equity financing has been led by Archangels Investors Ltd, with additional investment by Julz and the Scottish Investment Bank.
CALCiViS received significant funding through a prestigious Innovate UK Biomedical Catalyst award and secured a £2 million grant from the European Commission under its Horizon 2020 SME Instrument programme.
Over 500 million dental examinations per year in the US and EU
Market research indicates a high potential for the CALCiViS imaging system with over 500 million primary dental examinations each year in Europe and the USA.
CALCiViS and the global dental market
The CALCiViS imaging system incorporates an imaging device and a consumable kit which together fit well with existing dental industry business models.